125 related articles for article (PubMed ID: 11129544)
1. [Impact of antiretroviral therapy in mortality of Chilean HIV (+) patients: a case control study].
Wolff M; Bustamante C; Bidart T; Dabanch J; Diomedi A; Northland R
Rev Med Chil; 2000 Aug; 128(8):839-45. PubMed ID: 11129544
[TBL] [Abstract][Full Text] [Related]
2. [Prospective follow-up of a HIV infected population with and without access to antiretroviral therapy: impact of survival and complications].
Wolff M; Diomedi A; Morales O; Bidart T; Dabanch J; Bustamante C; Northland R
Rev Med Chil; 2001 Aug; 129(8):886-94. PubMed ID: 11680962
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
6. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
[TBL] [Abstract][Full Text] [Related]
9. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
10. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
11. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
12. [In old age ... AIDS. Is it worth to initiate antiretroviral treatment? Review of 37 patients more than 60 years of age].
de Górgolas M; Bello E; García Vázquez E; Moya MJ; García Delgado R; Fernández Guerrero ML
An Med Interna; 1999 Jun; 16(6):273-6. PubMed ID: 10422294
[TBL] [Abstract][Full Text] [Related]
13. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
[TBL] [Abstract][Full Text] [Related]
14. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
[TBL] [Abstract][Full Text] [Related]
15. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
Paton NI; Sangeetha S; Earnest A; Bellamy R
HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
[TBL] [Abstract][Full Text] [Related]
16. Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.
Oette M; Kurowski M; Feldt T; Kroidl A; Sagir A; Vogt C; Wettstein M; Häussinger D
J Antimicrob Chemother; 2005 Aug; 56(2):416-9. PubMed ID: 15983027
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antiretroviral treatment in two private medical centers in Addis, Ethiopia.
Habtegiorgis A; Gebreyesus S; Mulugeta E
Ethiop Med J; 2003 Oct; 41(4):345-51. PubMed ID: 15296416
[TBL] [Abstract][Full Text] [Related]
18. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
19. Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy.
Sobottke R; Zarghooni K; Krengel M; Delank S; Seifert H; Fätkenheuer G; Ernestus I; Källicke T; Frangen T; Arasteh K; Oette M; Eysel P
Spine (Phila Pa 1976); 2009 Jun; 34(13):E452-8. PubMed ID: 19478647
[TBL] [Abstract][Full Text] [Related]
20. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study.
Skiest DJ; Rubinstien E; Carley N; Gioiella L; Lyons R
Am J Med; 1996 Dec; 101(6):605-11. PubMed ID: 9003107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
